Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
2.490
-0.040 (-1.58%)
At close: Sep 15, 2026, 4:00 PM EDT
2.500
+0.010 (0.40%)
After-hours: Sep 15, 2026, 6:02 PM EDT

Fortress Biotech Revenue

Fortress Biotech had revenue of $18.72M in the quarter ending June 30, 2026, with 14.04% growth. This brings the company's revenue in the last twelve months to $68.47M, up 15.46% year-over-year. In the year 2025, Fortress Biotech had annual revenue of $63.26M with 9.69% growth.

Revenue (ttm)
$68.47M
Revenue Growth
+15.46%
P/S Ratio
1.23
Revenue / Employee
$877,769
Employees
78
Market Cap
83.04M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202563.26M5.59M9.69%
Dec 31, 202457.68M-26.84M-31.76%
Dec 31, 202384.51M8.77M11.58%
Dec 31, 202275.74M6.95M10.11%
Dec 31, 202168.79M23.19M50.86%
Dec 31, 202045.60M8.97M24.49%
Dec 31, 201936.63M9.75M36.26%
Dec 31, 201826.88M9.64M55.88%
Dec 31, 201717.25M11.09M180.09%
Dec 31, 20166.16M5.29M613.44%
Dec 31, 2015863.00K--
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Pelthos Therapeutics43.30M
ImmuCell30.68M
Verrica Pharmaceuticals30.32M
RenovoRx1.98M
Nutriband1.62M
MediciNova920.48K
Revenue Rankings